Estrogenic compounds as anti-mitotic agents
US6528676B1 · kind B1 · utility
30Cited by
7References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 1999 |
| Grant date | Mar 4, 2003 |
| Priority date | — |
| Expiry date | Feb 2, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J63/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The application discloses methods of treating mammalian diseases characterized by abnormal cell mitosis by administering estradiol derivatives including those comprising colchicine or combretastatin A-4 structural motifs of the general formulae found below in a dosage sufficient to inhibit cell mitosis. The application discloses novel compounds used in the methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.